New Data in Nature Medicine Suggest Pre-Treatment Tumor Microenvironment Can Impact Response for CAR T-Cell Therapy in Patients with Large B-Cell Lymphoma

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--New data published in Nature Medicine suggest Veracyte’s immuno-oncology biomarkers could help predict patient response to immunotherapies.

Click to view original post